Posted by Michael Wonder on 15 Apr 2021
NICE publishes draft guidance on new use for fenfluramine hydrochloride
15 April 2021 - The Department of Health and Social Care has asked NICE to produce guidance on using fenfluramine hydrochloride for the treatment of patients with Dravet syndrome in the NHS in England.
Fenfluramine hydrochloride is not recommended, within its marketing authorisation, as an add-on to other anti-epileptic medicines for treating seizures associated with Dravet syndrome in people aged 2 years and older.
There are multiple uncertainties in the economic modelling.
